136 results
8-K
EX-99.1
MTEM
Molecular Templates Inc
5 Jun 12
Threshold Pharmaceuticals Announces Highlights of TH-302 Presentations at 2012 American Society of Clinical Oncology Annual Meeting
12:00am
PHARMACEUTICALS ANNOUNCES HIGHLIGHTS OF TH-302 PRESENTATIONS
AT 2012 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING
SOUTH SAN FRANCISCO, CA – June 4, 2012 … -- Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced details from two clinical posters featured at theAmerican Society of Clinical
8-K
EX-99.1
MTEM
Molecular Templates Inc
1 Jul 13
Other Events
12:00am
with advanced soft tissue sarcoma, but response rates are generally low and toxicity can be significant. The American Cancer Society estimates about 11,410 … . Presented at the 37th European Society for Medical Oncology Congress; September 28-October 2, 2012; Vienna, Austria. Abstract LBA7.
Chawla SP, et al
8-K
MTEM
Molecular Templates Inc
10 Nov 22
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
4:30pm
.
Item 7.01. Regulation FD Disclosure.
Attached hereto as Exhibit 99.2 and incorporated by reference herein is the November 11, 2022 Society … November 10, 2022
99.2
Society for Immunotherapy of Cancer’s 37th Annual Meeting Presentation, dated November 11, 2022
Cover Page Interactive Data
8-K
EX-99.1
MTEM
Molecular Templates Inc
26 May 23
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
5:16pm
EXHIBIT 99.1
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO … Society of Clinical Oncology (“ASCO”) Annual Meeting, taking place June 2-6, 2023 in Chicago, IL. One-on-one meetings may be scheduled directly
8-K
EX-99.1
MTEM
Molecular Templates Inc
16 May 18
Molecular Templates to Present Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
5:00pm
EXHIBIT 99.1
Molecular Templates to Present Clinical Data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2018
ASCO Posters … unique mechanisms of action in oncology, today announced that data on two of its pipeline programs will be presented at the American Society of Clinical
8-K
EX-99.1
ztvbntviim5xco076zf
6 Jun 11
Other Events
12:00am
8-K
EX-99.1
5ifoehhzut9evb
16 Oct 12
Other Events
12:00am
8-K
EX-99.1
dxw t1c9h9
25 Feb 11
Other Events
12:00am
8-K
EX-99.1
whgvf3d7 av74w
19 Mar 12
Threshold Pharmaceuticals' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma
12:00am
8-K
EX-99.1
7bi8xiaxbym4ls08l8
12 Oct 10
Other Events
12:00am
8-K
EX-99.1
1u1762dxeo6acd04fx1q
17 Sep 12
Threshold Pharmaceuticals to Present Updated Data from Phase 2b
12:00am
8-K
EX-99.1
c2zdr an5h
30 Sep 11
Other Events
12:00am
8-K
EX-99.1
b3cddrad6begh
21 Sep 09
Threshold Pharmaceuticals Provides Clinical Trial Update from a Complete Phase 1/2 Clinical Trial of TH-302 In Combination with Chemotherapy
12:00am
8-K
EX-99.1
6sjnaa2z9 6ve5ctkeq
11 Aug 22
Molecular Templates, Inc. Reports Second Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
1sd796k7n77vbf neyz
22 Sep 14
Other Events
12:00am
8-K
EX-99.1
kw1cprbc8kdp2
8 Mar 12
Threshold Pharmaceuticals Reports Fourth Quarter and Year end 2011 Financial AND OPERATIONAL Results
12:00am
8-K
EX-99.1
36yosxer 51ktv6
11 Dec 13
Other Events
12:00am
8-K
EX-99.1
gzzdg9ghi sn
12 Nov 19
Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results
5:00pm
8-K
EX-99.1
g8wgwd3jkulh3rr3sncd
3 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
rij64uml5n75 cxixs
11 Dec 13
Other Events
12:00am